Screening for reproductive toxicity in Fundulus heteroclitus by genetic expression profiling

References

• Armstrong P. B., Child J. S. Stages in the normal development of Fundulus heteroclitus. Biological Bulletin. MBL Publishers, Massachusetts and New York 1965; 143–168
   Google Scholar
• Bohn M. C. Granule cell genesis in hippocampus of rats treated with hydrocortisone. Neuroscience 1980; 5(11)2003–2012
   PubMedGoogle Scholar
• Casarett L. J., Doull J. Toxicology: the Basic Science of Poisons, 2nd edition. Macmiflan Publishing Co., Inc., New York 1980
   Google Scholar
• Casarett L. J., Doull J. Toxicology: the Basic Science of Poisons, 5th edition. McGraw-Hill Co., Inc., New York 1996
   Google Scholar
• Copp A. J., Brook F. A., Estbeiro J. P., Shum A. S. W., Cockroft D. L. The embryonic development of mammalian neural tube defects. Progress in Neurobiology 1990; 5: 363–403
   Google Scholar
• Dencker L., Nau H., D'Argy R. Marked accumulation of valproic acid in embryonic neuroepithelium of the mouse during early organogenesis. Teratology 1990; 44: 699–706
   Google Scholar
• DeYoung D. J., Bantle J. A., Fort D. J. Assessment of the developmental toxicity of ascorbic acid, sodium selenate, coumarin, serotonin, and 13-cis retinoic acid using FETAX. Drug and Chemical Toxicology 1991; 14(1–2)127–141
   PubMed Web of Science ®Google Scholar
• Doppler W., Groner B., Ball R. K. Prolactin and glucocorticoid hormones synergistically induce expression of transfected rat beta-casein gene promoter constructs in a mammary epithelial cell line. Proceedings of the National Academy of Sciences, USA 1989; 86: 104–108
   PubMed Web of Science ®Google Scholar
• Eberwine J. H., Yeh H., Miyashiro K., Cao Y., Nair S., Finnell R. H., Zettel M., Coleman P. Analysis of gene expression in single live neurons. Proceedings of the National Academy of Sciences, USA 1992a; 89: 3010–3014
   PubMed Web of Science ®Google Scholar
• Eberwine J. H., Spencer C., Miyashiro K., Mackler S., Finnell R. H. cDNA synthesis in situ: Methods and applications. Methods in Enzymology, G. Wu. Academic Press, New York 1992b; Vol. 216: 80–100
   Google Scholar
• Finnell R. H. Genetic differences in susceptibility to anticonvulsant drug induced developmental defects. Pharmacology and Toxicology 1991; 69: 223–227
   PubMedGoogle Scholar
• Finnell R. H., Bennett G. D., Karras S. B., Mohl V. K. Common hierarchies of susceptibility to the induction of neural tube defects in mouse embryos by valproic acid and its 4-propyl-4-pentenoic acid metabolite. Teratology 1988; 38: 313–320
   PubMedGoogle Scholar
• Finnell R. H., Nau H., Yerby M. S. General principles: teratogenicity of antiepileptic drugs. Antiepileptic Drugs, R. H. Levy, R. H. Mattson, B. S. Meldrum. Raven Press, Ltd, New York 1995; 209–230
   Google Scholar
• Flint Y. B., Levkowitz G., Vardimon L. Involvement of c-Jun in the control of glucocorticoid receptor transcriptional activity during development of chicken retinal tissue. European Molecular Biology Organization Journal 1994; 13(3)646–654
   PubMedGoogle Scholar
• Funder J. W. Mineralocorticoids, glucocorticoids, receptors and response elements. Science 1993; 259: 1132–1133
   PubMed Web of Science ®Google Scholar
• Fuxe K, Cintra A., Chadi G., Gustafsson J. A., Agnati L. F. Central glucocorticoid receptors and neuronal plasticity. Neurobiology of Steroids, E. R. de Kloet, W. Sutanto. Academic Press, New York 1994; Vol. 22: 372–382
   Google Scholar
• German J. Embryonic stress hypothesis of teratogenesis. American Journal of Medicine 1984; 76: 293–301
   PubMedGoogle Scholar
• Gibson J. E. Teratology studies in mice with 2-sec-butyl-4,6-dinitrophenol (Dinoseb). Fundamentals in Cosmetic Toxicology 1973; 11: 31–43
   PubMedGoogle Scholar
• Goodman L. S., Gilman A. Goodman and Gilman's: The Pharmacological Basis of Therapeutics, 8th edition. McGraw-Hill, Inc., New York 1993
   Google Scholar
• How R. D., Vedel-Macrander G. C., Zaworotko M. J., Tatum F. M., Meeks A. G. Distribution, metabolism, and fetal uptake of pentavalent arsenic in pregnant mice following oral or intraperioneal administration. Teratology 1987; 35: 19–25
   PubMedGoogle Scholar
• Kalinyak J. E., Dorin R. I., Hoffman A. R., Perlman A. J. Tissue specific regulation of glucocorticoid receptor mRNA by dexamethasone. Journal of Biological Chemistry 1987; 262(22)10441–10444
   PubMedGoogle Scholar
• Kao J., Brown N. A., Schmdt B., Goulding E. H., Fabro S. Teratogenicity of valproic acid: In vivo and in vitro investigations. Teratogenesis, Carcinogenesis and Mutagenesis 1981; 1: 367–382
   Google Scholar
• Keen C. L., Taubeneck M. W., Daston G. P., Gershwn M. E., Ansari A., Togers J. M. Primary and secondary zinc deficiency as factors contributing to abnormal central nervous system development. Developmental Brain Dysfunction 1995; 8: 78–89
   Google Scholar
• Keaft J. C., Lofberg B., Chahoud I., Bochert G., Nau H. Teratogenicity and placental transfer of all-trans-, 13-cis-, 4-oxo-all-trans-and 4-oxo-13-cis-retinoic acid after administration of a low oral dose during organogenesis in mice. Toxicology and Applied Pharmacology 1989; 100: 162–176
   PubMedGoogle Scholar
• Lammer E. J., Sever L. E., Oakley G. P. Teratogen update: valproic acid. Teratology 1987; 35: 465–473
   PubMedGoogle Scholar
• Loscher W. Pharmacological, toxicological and neurochemical effects of D2(E)-valproate in animals. Pharmaceutisch Weekblad Scientific 1992; 14(3A)139–143
   PubMedGoogle Scholar
• Mackler S. A., Bennett G. D., Tsuei V., Finnell R. H. Cocaine exposure selectivity alters levels of neurotransmitter receptor mRNAs in murine embryos. Reproductive Toxicology 1996; 10: 37–42
   PubMedGoogle Scholar
• Mast T. J., Cukierski M. A., Nau H., Hendrickx A. G. Predicting the human teratogenic potential of the anticonvulsant, valproic acid, from a non human primate model. Toxicology 1986; 39: 111–119
   PubMed Web of Science ®Google Scholar
• Miesfeld R., Rusconi S., Godowski P. J., Maler B. A., Okret P. J., Wilkstrom A. C., Gustafsson J., Yamamoto K. R. Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA. Cell 1986; 46(3)389–399
   PubMed Web of Science ®Google Scholar
• Miyashiro K., Finnell R. H., Ouyang A., Spencer C. M., Mackler S. A., Eberwine J. H. In situ transcription: methodology and multifaceted applications. In Situ Hybridization: Applications to Neurobiology, J. H. Eberwine, K. Valentino, J. Barchas. Cold Spring Harbor Press, Cold Spring Harbor, New York 1993; Vol. 11
   Google Scholar
• Morrissey R. E., Mottet N. K. Arsenic-induced exencephaly in the mouse and associated lesions occurring during neurulation. Teratology 1983; 28: 399–411
   PubMedGoogle Scholar
• Mpttet N. K., Ferm V. H. The congenital teratogeniclty and perinatal toxicity of metals. Reproduction and Developmental Toxicity of Metals, T. W. Clarkson, G. F. Nordberg, P. R. Sager. Plenum Press, New York 1983
   Google Scholar
• Nau H. Teratogenic valproic acid concentrations: infusion by implanted minipumps vs conventional regimen in the mouse. Toxicology and Applied Pharmacology 1985; 80: 243–250
   PubMed Web of Science ®Google Scholar
• Nau H. Valproic acid-induced neural tube defects. Neural Tube Defects. Wiley, Chichester 1994; 144–160, Ciba Foundation Symposium 181
   Google Scholar
• Nau H., Loscher W. Pharmocologic evaluation of various metabolites and analogs of valproic acid: teratogenic potencies in mice. Fundamental and Applied Toxicology 1986; 6: 669–676
   PubMedGoogle Scholar
• Ong L. I., Schardein J. L., Petrere J. A., Sakowski R., Jordan H., Humphrey R., Fitzgerald J. E., Iglesia F. A. Teratogenesis of calcium valproate in rats. Fundamental and Applied Toxicology 1983; 3: 121–126
   PubMedGoogle Scholar
• Padanabhan R., Hmeed M. S. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse. Journal of Craniofacial Genetics Developmental Biology 1994; 14: 192–205
   PubMedGoogle Scholar
• Pearce D., Yamamoto K. R. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 1993; 259: 1161–1164
   PubMedGoogle Scholar
• Robert E. Valproic acid in pregnancy—association with spina bifida: a preliminary report. Clinical Pediatrics 1982; 22(5)336
   Google Scholar
• Rosa F. W., Wilk A. L., Kelsey F. O. Teratogen update: vitamin A congeners. Teratology 1986; 33: 355–364
   PubMedGoogle Scholar
• SAS Institute. SAS/STAT User's Guide. SAS Institute, Inc., North Carolina 1990; Volumes I and II
   Google Scholar
• Sato M., Shirota M., Nagao T. Pantothenic acid decreases valproic acidinduced neural tube defects in mice (I). Teratology 1995; 52: 143–148
   PubMedGoogle Scholar
• Schumacher H. J. Chemicals structure and teratogenic properties. Methods for Detection of Environmental Agents that Produce Congenital Defects, T. H. Shepard, J. R. Miller, M. Marois. NorthHolland, Amsterdam 1975; 65–77
   Google Scholar
• Shalet S. L., Walker D. R., Finnell R. H. The role of arsenic as a reproductive toxin with particular attention to neural tube defects. Journal of Toxicology and Environmental Health 1996; 48: 101–120
   Google Scholar
• Shepard T. H. Catalog of Teratogenic Agents, 7th edition. Johns Hopkins University Press, Baltimore 1992
   Google Scholar
• Sonada T, Ohdo S., Ohba K. I., Okishima T., Hayakawa K. Sodium valproateinduced cardiovascular abnormalities in the Jcl:ICR mouse fetus: Peak sensitivity of gestational day and dose-dependent effect. Teratology 1993; 48: 127–132
   PubMedGoogle Scholar
• Svec F. Glucocorticoid receptor regulation. Life Sciences 1985; 36: 2369–2366
   Google Scholar
• Taylor L. E., Bennett G. D., Finnell R. H. Altered gene expression in murine branchial arches following in utero exposure to retinoid acid. Journal of Craniofacial Genetics and Developmental Biology 1995; 15: 13–25
   PubMedGoogle Scholar
• Theodosis D. T, Fraser F. C. Early changes in the mouse neuroepithelium preceding exencephaly induced by hypervitaminosis. Teratology 1978; 18: 219–232
   PubMedGoogle Scholar
• Tseng W. P. Effects and dose response relationships of skin cancer and blackfoot disease with arsenic. Environmental Health Perspectives 1977; 19: 109–119
   PubMed Web of Science ®Google Scholar
• Vardimon L., Dror B. I., Havazelet N., Fox L. E. Molecular control of glutamine synthetase expression in the developing retina tissue. Developmental Dynamics 1993; 196: 276–282
   PubMedGoogle Scholar
• Weinberg R. The action of oncogenes in the cytoplasm and nucleus. Science 1985; 230: 77C–778
   Google Scholar
• Whillhiste C. C., Ferm V. H. Prenatal and developmental toxicology of arsenicals. Advances in Experimental Medical Biology 1984; 177: 205–228
   PubMedGoogle Scholar
• Whittle B. A. Preclinical, teratological studies on sodium valproate and other anticonvulsants. Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy, N. Legg. MCS Consultants, Tunbridge WellsUK 1976; 105–110
   Google Scholar
• Zimmerman E. F. Chemical structure and teratogenic mechanism of action. Methods for Detection of Environmental Agents that Produce Congenital Defects, T H. Shepard, J. R. Miller, M. Marois. North Holland, Amsterdam 1975; 79–88
   Google Scholar